Pelage PP405: New Hair Growth from Inactive Follicular Units - Phase 2a results at AAD 2026
    Research/Science 3/29/2026

    At a glance
    In this research update post, the primary subjects mentioned are
    💧 PP405 (topical) 0.05% once daily 28 days
    the tone is 😀 positive with promising results.

    Other terms

    PP405, a topical treatment, shows promise for hair growth by activating inactive follicles, with 66% of participants experiencing positive results. The treatment is well-tolerated and may proceed directly to Phase 3 trials, offering a potential alternative to minoxidil and finasteride.
    View this post in the Community →

    Similar Community Posts Join

    5 / 539 results

      community Pelage Announces Positive Results of Phase 2a Trials for PP405

      in Update  300 upvotes 1 year ago
      PP405 shows promise in treating severe hair loss, with 31% of users experiencing over 20% hair density increase in four weeks, faster than minoxidil and finasteride. Some users are skeptical about the results' significance and long-term efficacy.

      community Most promising cures for baldness as of May 2026

      in Treatment  56 upvotes 1 month ago
      PP405 is the most promising future treatment for hair loss, aiming to reactivate dormant hair follicles. Clascoterone 5% is the most promising near-term drug, while current strategies include using finasteride or dutasteride to stabilize hair loss and minoxidil to stimulate growth.

      community Sooo whats the consensus about pp405 now?

      in Chat  75 upvotes 3 months ago
      PP405 may help with hair regrowth, especially when combined with minoxidil and finasteride, but its long-term effectiveness is unclear. Phase 3 trials are expected to begin soon, with results in a few years.
      PP405 Identity Research

      community PP405 Identity Research

      in Research  292 upvotes 10 months ago
      PP405 is a potential hair loss treatment that inhibits mitochondrial pyruvate carriers, increasing lactate dehydrogenase activity and stimulating hair follicle stem cells. In a phase 1 trial, 31% of participants showed over 20% hair density increase with PP405 treatment.

    Related Research

    6 / 22 results